Skip to content
تگاسرود

Structure via PubChem · Public domain (PubChem)

EntityQ44944· pop 16· linked from 1,418 articles

تگاسرود

Sign in to save

Also known as HTF919, SDZ-HTF-919, 1-{[(5-Methoxyindol-3-yl)methylene]amino}-3-pentylguanidine, (E)-tegaserod

Tegaserod is a 5-HT4 agonist manufactured by Novartis and sold under the names Zelnorm and Zelmac for the management of irritable bowel syndrome and constipation. Approved by the FDA in 2002, it was subsequently removed from the market in 2007 due to FDA concerns about possible adverse cardiovascular effects. Before then, it was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating, and constipation associated with irritable bowel syndrome. Its use was also approved to treat chronic idiopathic constipation.

Chemical data

Formula
C16H23N5O
Molecular weight
301.39 g/mol
IUPAC name
1-[(E)-(5-methoxy-1H-indol-3-yl)methylideneamino]-2-pentylguanidine
SMILES
CCCCCN=C(N)N/N=C/C1=CNC2=C1C=C(C=C2)OC
InChIKey
IKBKZGMPCYNSLU-RGVLZGJSSA-N
XLogP
2.6
Polar surface area
87.8 Ų
H-bond donors
3
H-bond acceptors
3
Formal charge
0

via PubChem

Drug data · ChEMBL

Withdrawn
Max clinical phase
Approved
Molecule type
Small molecule
First approval
2002
Admin. routes
oral
Indications
gastroesophageal reflux disease, Constipation, dyspepsia

via ChEMBL · EBI

Research

542 papers

via PubMed

Wikidata facts

Subclass of
indole alkaloid
Mass
301.190260356
Has use
medication
Show 10 more facts
defined daily dose
12
chemical formula
C₁₆H₂₃N₅O
canonical SMILES
CCCCCNC(=N)NN=CC1=CNC2=C1C=C(OC)C=C2
World Health Organisation international non-proprietary name
tegaserod
medical condition treated
constipation
NCI Thesaurus ID
C66583
Commons category
Tegaserod
found in taxon
Geodia barretti
isomeric SMILES
CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12
Sources (5)

via Wikidata · CC0